(CNN) A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after three to six months in a small study
A primary concern for patients anchoring into the Hepaglide 2.4 mg Pre-filled Pen is whether they can stay on this maximum maintenance dose indefinitely. From a clinical perspective, the 2.4 mg strength is specifically evaluated and approved for long-term chronic management. Once your body reaches its targeted weight profile, staying on this steady maintenance baseline prevents the body's natural defensive tendency to slowly regain fat reserves, keeping your metabolic health stable and secured over extended periods
Most would likely not recommend stopping treatment based on current evidence, but individual circumstances vary
Compounded semaglutide , on the other hand, comes in vials with a known concentration, typically expressed in mg/mL
Teplizumab is an immunotherapy that works by modifying the immune response, helping to slow the progression of Type 1 diabetes